Total Payments
$2,727
2024 Payments
$622.54
Companies
25
Transactions
103
Medicare Patients
1,184
Medicare Billing
$276,721
Payment Breakdown by Category
Food & Beverage$2,710 (99.4%)
Education$16.89 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,710 | 102 | 99.4% |
| Education | $16.89 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $435.25 | 9 | $0 (2024) |
| Travere Therapeutics, Inc. | $413.84 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $386.70 | 17 | $0 (2023) |
| Relypsa, Inc. | $248.23 | 12 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $156.62 | 9 | $0 (2023) |
| Vifor Pharma, Inc. | $148.81 | 10 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $136.31 | 7 | $0 (2024) |
| Mallinckrodt LLC | $124.80 | 6 | $0 (2018) |
| Veloxis Pharmaceuticals, Inc. | $115.96 | 1 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $90.63 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $622.54 | 13 | Travere Therapeutics, Inc. ($266.88) |
| 2023 | $789.53 | 30 | AstraZeneca Pharmaceuticals LP ($193.06) |
| 2021 | $106.59 | 7 | Vifor Pharma, Inc. ($41.25) |
| 2020 | $46.79 | 3 | Fresenius USA Marketing, Inc. ($18.27) |
| 2019 | $491.28 | 20 | Veloxis Pharmaceuticals, Inc. ($115.96) |
| 2018 | $319.72 | 13 | Otsuka America Pharmaceutical, Inc. ($163.44) |
| 2017 | $350.56 | 17 | Relypsa, Inc. ($172.87) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $125.09 | General |
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $91.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.90 | General |
| 06/06/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: NEPHROLOGY | ||||||
| 05/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Nephrology | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $106.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.29 | General |
| 12/05/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: NEPHROLOGY | ||||||
| 10/18/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $117.70 | General |
| 10/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardio-renal | ||||||
| 10/05/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEPHROLOGY | ||||||
| 09/27/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: NEPHROLOGY | ||||||
| 09/22/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: Nephrology | ||||||
| 08/31/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: KRYSTEXXA | ||||||
| 07/21/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: NEPHROLOGY | ||||||
| 07/13/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Hyperkalemia | ||||||
| 06/29/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.08 | General |
| 06/15/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 12 | 517 | 1,394 | $323,534 | $99,883 |
| 2020 | 11 | 667 | 2,349 | $571,034 | $176,838 |
Total Patients
1,184
Total Services
3,743
Medicare Billing
$276,721
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 161 | 797 | $133,896 | $42,170 | 31.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 107 | 135 | $47,250 | $19,715 | 41.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 63 | 156 | $55,692 | $11,872 | 21.3% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 11 | 42 | $16,800 | $5,869 | 34.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 28 | 32 | $11,776 | $3,711 | 31.5% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 22 | 26 | $6,552 | $3,520 | 53.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 22 | 58 | $6,380 | $3,345 | 52.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 38 | 40 | $9,000 | $3,189 | 35.4% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 24 | 51 | $25,500 | $2,790 | 10.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 31 | $4,960 | $2,719 | 54.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 13 | 14 | $2,128 | $683.76 | 32.1% |
| 99224 | Subsequent observation care, typically 15 minutes per day | Facility | 2021 | 12 | 12 | $3,600 | $298.79 | 8.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 212 | 1,444 | $242,592 | $80,726 | 33.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 158 | 203 | $71,050 | $29,512 | 41.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 114 | 284 | $101,388 | $22,984 | 22.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 14 | 60 | $34,800 | $11,206 | 32.2% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 14 | 69 | $27,600 | $10,402 | 37.7% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 37 | 115 | $57,500 | $6,613 | 11.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 48 | 56 | $12,600 | $4,614 | 36.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 18 | 23 | $8,464 | $3,073 | 36.3% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 19 | 20 | $5,040 | $2,881 | 57.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 35 | $5,600 | $2,657 | 47.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 16 | 40 | $4,400 | $2,170 | 49.3% |
About Dr. Branislav Marcic, MD
Dr. Branislav Marcic, MD is a Nephrology healthcare provider based in Merrillville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356396378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Branislav Marcic, MD has received a total of $2,727 in payments from pharmaceutical and medical device companies, with $622.54 received in 2024. These payments were reported across 103 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,710).
As a Medicare-enrolled provider, Marcic has provided services to 1,184 Medicare beneficiaries, totaling 3,743 services with total Medicare billing of $276,721. Data is available for 2 years (2020–2021), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Merrillville, IN
- Active Since 05/24/2006
- Last Updated 10/29/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1356396378
Products in Payments
- Veltassa (Drug) $397.04
- JYNARQUE (Drug) $337.53
- LOKELMA (Drug) $277.44
- ACTHAR (Biological) $158.30
- FARXIGA (Drug) $157.81
- Envarsus (Drug) $115.96
- Velphoro (Drug) $104.35
- RAYALDEE (Drug) $98.48
- Kerendia (Drug) $70.02
- TARPEYO (Drug) $58.61
- SAMSCA (Drug) $49.17
- Parsabiv (Biological) $39.23
- Rayaldee (Drug) $37.83
- TAVNEOS (Drug) $37.21
- GATTEX (Drug) $27.05
- LUPKYNIS (Drug) $25.92
- Mitigare (Drug) $25.76
- FreeStyle Lite system (Device) $23.33
- NATPARA (PARATHYROID HORMONE) (Drug) $20.39
- Ozempic (Drug) $20.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Merrillville
Dr. Vikash Sinha, Md, MD
Nephrology — Payments: $14,696
Nephrology $14,696
Dr. Kevin Myrie, M.d,, M.D,
Nephrology — Payments: $14,572
Nephrology $14,572
Venkat Vavilala, Md, MD
Nephrology — Payments: $9,175
Nephrology $9,175
Kenneth Choi, Md, MD
Nephrology — Payments: $6,803
Nephrology $6,803
Dr. Saurabh Chawla, M.d, M.D
Nephrology — Payments: $6,358
Nephrology $6,358
Gaurav Alreja, M.d, M.D
Nephrology — Payments: $5,779
Nephrology $5,779